Qualigen Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Qualigen Therapeutics (QLGN) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Qualigen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Qualigen Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Qualigen Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $42 | 252 | 0.17 |
| 2024-06-30 | $42 | 252 | 0.17 |
| 2024-03-31 | $111 | 286 | 0.39 |
| 2023-12-31 | $211 | 386 | 0.55 |
| 2023-09-30 | $390 | 387 | 1.01 |
| 2023-06-30 | $351 | 385 | 0.91 |